Pure Global

Assessing Mobile Apps for Adult ADHD - Trial NCT06256003

Access comprehensive clinical trial information for NCT06256003 through Pure Global AI's free database. This phase not specified trial is sponsored by Think Now Incorporated and is currently Recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06256003
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06256003
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Assessing Mobile Apps for Adult ADHD
A Randomized, Controlled, Parallel-Group, Intervention Study to Assess At-Home, Digital Therapy for Treating Adult Participants Ages 18-50 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

Study Focus

UC-A

Interventional

device

Sponsor & Location

Think Now Incorporated

Berkeley,Los Angeles, United States of America

Timeline & Enrollment

N/A

Jan 03, 2024

Oct 01, 2024

140 participants

Primary Outcome

Conners Continuous Performance Task (CPT3) - HRT Std (Change from Baseline to Midpoint Mid-treatment, and Baseline to Endpoint Post-treatment)

Summary

The purpose of this clinical trial is to evaluate the effects of mobile app digital therapies
 on cognitive function and symptoms in adults diagnosed with ADHD.

ICD-10 Classifications

Neurotic disorder, unspecified
Hyperkinetic disorder, unspecified
Habit and impulse disorder, unspecified
Mild cognitive disorder
Disturbance of activity and attention

Data Source

ClinicalTrials.gov

NCT06256003

Device Trial